journal article·2023Open access

Functional nucleic acids for the treatment of diabetic complications

Wen Wen, Yuzi Wei, Shaojingya Gao

Nanoscale Advances· Volume 5· Issue 20

Abstract

In recent decades, diabetes mellitus (DM) has become a major global health problem owing to its high prevalence and increased incidence of diabetes-associated complications, including diabetic wounds (DWs), diabetic nephropathy, metabolic syndrome, diabetic retinopathy, and diabetic neuropathy. In both type 1 and type 2 diabetes, tissue damage is organ-specific, but closely related to the overproduction of reactive oxygen species (ROS) and hyperglycaemia-induced macrovascular system damage. However, existing therapies have limited effects on complete healing of diabetic complications. Fortunately, recent advances in functional nucleic acid materials have provided new opportunities for the treatment and diagnosis of diabetic complications. Functional nucleic acids possess independent structural functions that can replace traditional proteases and antibodies and perform specific biological non-genetic functions. This review summarises the current functional nucleic acid materials reported for the treatment of diabetic complications, including tetrahedral framework nucleic acids (tFNAs), short interfering RNA (siRNA), micorRNA (miRNA), locked nucleic acids, antisense oligonucleotides (ASOs), and DNA origami, which may assist in the development of novel nucleic acids with new functions and capabilities for better healing of diabetic complications.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China

Funding

Sichuan University · China Postdoctoral Science Foundation

References (100+)

Show source-provided references
1. El-Say · Int. J. Nanomed. · 2022 · 17 · 178310.2147/IJN.S357356 ↗
2. Saeedi · Diabetes Res. Clin. Pract. · 2019 · 157 · 10784310.1016/j.diabres.2019.107843 ↗
3. Najafi · Brain Res. Bull. · 2017 · 131 · 11710.1016/j.brainresbull.2017.03.013 ↗
4. Faselis · Curr. Vasc. Pharmacol. · 2020 · 18 · 11710.2174/1570161117666190502103733 ↗
5. Pfannkuche · Endocr. Metab. Sci. · 2020 · 1 · 10005310.1016/j.endmts.2020.100053 ↗
6. Zhang · J. Diabetes Res. · 2020 · 2020
7. do Vale Moreira · Diabetes Metabol. Syndr. · 2020 · 14 · 121710.1016/j.dsx.2020.05.043 ↗
8. Sabanayagam · Lancet Diabetes Endocrinol. · 2019 · 7 · 14010.1016/S2213-8587(18)30128-1 ↗
9. Ponirakis · Diabetes Metabol. Res. Rev. · 2020 · 36 · e328610.1002/dmrr.3286 ↗
10. Tan · Diabetes, Metab. Syndrom · 2019 · 13 · 36410.1016/j.dsx.2018.10.008 ↗
11. Xu · Angew Chem. Int. Ed. Engl. · 2021 · 60 · 689010.1002/anie.201909927 ↗
12. Lin · ACS Appl. Mater. Interfaces · 2020 · 12 · 1139710.1021/acsami.0c00874 ↗
13. Guo · J. Dent. Res. · 2010 · 89 · 21910.1177/0022034509359125 ↗
14. Wang · Theranostics · 2019 · 9 · 6510.7150/thno.29766 ↗
15. Zhou · J. Ethnopharmacol. · 2022 · 282 · 11466210.1016/j.jep.2021.114662 ↗
16. D. F.Bandyk , The diabetic foot: pathophysiology, evaluation, and treatment , in Seminars in vascular surgery , Elsevier , 2018
17. Zhu · Signal Transduct. Targeted Ther. · 2020 · 5 · 110.1038/s41392-019-0089-y ↗
18. Tian · Adv. Funct. Mater. · 2021 · 31 · 200734210.1002/adfm.202007342 ↗
19. Liu · Nano Today · 2021 · 38 · 10121110.1016/j.nantod.2021.101211 ↗
20. Li · Mater. Today · 2019 · 24 · 5710.1016/j.mattod.2018.08.002 ↗
21. Simons · Nat. Rev. Mol. Cell Biol. · 2016 · 17 · 61110.1038/nrm.2016.87 ↗
22. Hotkar · Int. Wound J. · 2015 · 12 · 21010.1111/iwj.12084 ↗
23. Ren · J. Cell. Mol. Med. · 2020 · 24 · 1235510.1111/jcmm.15725 ↗
24. Perini · BMC Compl. Alternative Med. · 2015 · 15 · 110.1186/s12906-015-0520-z ↗
25. Bhikha · Am. J. Intern. Med. · 2018 · 6 · 99
26. Zhang · Bioact. Mater. · 2022 · 8 · 36810.1016/j.bioactmat.2021.06.003 ↗
27. Soares · Diabetes · 2016 · 65 · 63310.2337/db15-0453 ↗
28. Rabbani · Diabetes · 2019 · 68 · 14110.2337/db18-0232 ↗
29. Kasiewicz · Bioeng. Transl. Med. · 2019 · 4 · 7510.1002/btm2.10123 ↗
30. Rebane · J. Allergy Clin. Immunol. · 2014 · 134 · 83610.1016/j.jaci.2014.05.022 ↗
31. Wang · J. Invest. Dermatol. · 2014 · 134 · 144610.1038/jid.2013.532 ↗
32. Randeria · Proc. Natl. Acad. Sci. U.S.A. · 2015 · 112 · 557310.1073/pnas.1505951112 ↗
33. Samsu · BioMed Res. Int. · 2021 · 2021 · 149744910.1155/2021/1497449 ↗
34. Wang · Int. J. Mol. Sci. · 2021 · 22 · 788110.3390/ijms22157881 ↗
35. Donate-Correa · J. Clin. Med. · 2020 · 9 · 45810.3390/jcm9020458 ↗
36. Alvarez · Diabetologia · 2013 · 56 · 44410.1007/s00125-012-2768-x ↗
37. Zhang · ACS Appl. Mater. Interfaces · 2020 · 12 · 4711510.1021/acsami.0c13806 ↗
38. Kato · Proc. Natl. Acad. Sci. U. S. A. · 2007 · 104 · 343210.1073/pnas.0611192104 ↗
39. Fluiter · Nucleic Acids Res. · 2003 · 31 · 95310.1093/nar/gkg185 ↗
40. Putta · J. Am. Soc. Nephrol. · 2012 · 23 · 45810.1681/ASN.2011050485 ↗
41. Li · Mol. Ther. Nucleic Acids · 2022 · 28 · 48810.1016/j.omtn.2022.04.002 ↗
42. Wang · Int. J. Mol. Med. · 2018 · 41 · 2784
43. Gale · Am. J. Med. · 2018 · 131 · 116110.1016/j.amjmed.2018.01.022 ↗
44. Fan · Sci. Rep. · 2017 · 7 · 110.1038/s41598-016-0028-x ↗
45. Li · EBioMedicine · 2020 · 51 · 10258210.1016/j.ebiom.2019.11.043 ↗
46. Shahzad · J. Am. Soc. Nephrol. · 2021 · 32 · 306610.1681/ASN.2021040431 ↗
47. Hinder · Exp. Neurol. · 2018 · 305 · 3310.1016/j.expneurol.2018.03.011 ↗
48. Feldman · Nat. Rev. Dis. Prim. · 2019 · 5 · 4210.1038/s41572-019-0097-9 ↗
49. Straube · Horm. Metab. Res. · 2019 · 51 · 77910.1055/a-1039-1471 ↗
50. Ziegler · J. Diabetes Investig. · 2020 · 11 · 127210.1111/jdi.13267 ↗
51. Ozaki · J. Toxicol. Pathol. · 2018 · 31 · 12510.1293/tox.2017-0063 ↗
52. Sharma · J. Roy. Coll. Phys. Edinb. · 2020 · 50 · 26910.4997/jrcpe.2020.310 ↗
53. Lo · Front. Physiol. · 2017 · 8 · 55110.3389/fphys.2017.00551 ↗
54. Feng · Drug. Des. Devel. Ther. · 2018 · 12 · 17110.2147/DDDT.S157109 ↗
55. Luo · Nanomedicine · 2019 · 17 · 18810.1016/j.nano.2019.01.007 ↗
56. Bernier · Br. J. Pharmacol. · 2018 · 175 · 221910.1111/bph.13957 ↗
57. Wang · Purinergic Signal. · 2016 · 12 · 13910.1007/s11302-015-9488-x ↗
58. Xiong · Int. J. Clin. Exp. Pathol. · 2017 · 10 · 9960
59. Liu · BioMed Res. Int. · 2017 · 2017 · 7831251
60. Peng · Mol. Neurobiol. · 2017 · 54 · 51110.1007/s12035-015-9632-1 ↗
61. Takayama · Adv. Exp. Med. Biol. · 2018 · 1099 · 2910.1007/978-981-13-1756-9_3 ↗
62. Akhilesh · Life Sci. · 2022 · 288 · 12018710.1016/j.lfs.2021.120187 ↗
63. Liu · Neuroscience · 2018 · 374 · 21410.1016/j.neuroscience.2018.01.049 ↗
64. Matta · J. Diabetes Res. · 2018 · 2018 · 560135110.1155/2018/5601351 ↗
65. Agashe · Methodist Debakey Cardiovasc. J. · 2018 · 14 · 25110.14797/mdcj-14-4-251 ↗
66. Wu · Auton. Neurosci. · 2016 · 197 · 1410.1016/j.autneu.2016.04.001 ↗
67. Rothemund · Nature · 2006 · 440 · 29710.1038/nature04586 ↗
68. Pal · Front. Chem. · 2021 · 9 · 72110510.3389/fchem.2021.721105 ↗
69. Khatami · Biotechnol. Appl. Biochem. · 2022 · 69 · 93910.1002/bab.2165 ↗
70. Linko · Chem. Commun. · 2015 · 51 · 535110.1039/C4CC08472A ↗
71. Jiang · Adv. Mater. · 2019 · 31 · e180478510.1002/adma.201804785 ↗
72. Bastings · Nano Lett. · 2018 · 18 · 355710.1021/acs.nanolett.8b00660 ↗
73. Wang · J. Am. Chem. Soc. · 2018 · 140 · 247810.1021/jacs.7b09024 ↗
74. Thomas · Diabetologia · 2019 · 62 · 51710.1007/s00125-018-4797-6 ↗
75. Jiang · Int. Immunopharmacol. · 2020 · 88 · 10698910.1016/j.intimp.2020.106989 ↗
76. Lange · Clin. Exp. Ophthalmol. · 2018 · 46 · 75710.1111/ceo.13168 ↗
77. Antoszyk · JAMA · 2020 · 324 · 238310.1001/jama.2020.23027 ↗
78. Takao · J Diabetes Investig · 2020 · 11 · 93010.1111/jdi.13194 ↗
79. Lin · J Diabetes Investig · 2021 · 12 · 132210.1111/jdi.13480 ↗
80. Detwiler · Yale J. Biol. Med. · 2018 · 91 · 49
81. Liu · J. Neuroinflammation · 2022 · 19 · 26210.1186/s12974-022-02626-4 ↗
82. Qin · Nanoscale · 2019 · 11 · 2066710.1039/C9NR07171G ↗
83. Li · ACS Appl. Mater. Interfaces · 2021 · 13 · 4035410.1021/acsami.1c11468 ↗
84. Meng · Molecules · 2021 · 2610.3390/molecules26010229 ↗
85. Tian · J. Sci. Food Agric. · 2020 · 100 · 139210.1002/jsfa.10152 ↗
86. Li · Nanomicro Lett. · 2021 · 13 · 8610.3847/1538-4357/ac06c8 ↗
87. Lu · Exp. Eye Res. · 2020 · 190 · 10788610.1016/j.exer.2019.107886 ↗
88. Wang · J. Physiol. · 2019 · 597 · 306910.1113/JP277704 ↗
89. Mitra · J. Control Release · 2016 · 236 · 3110.1016/j.jconrel.2016.06.020 ↗
90. Cao · Future Med. Chem. · 2021 · 13 · 122710.4155/fmc-2021-0071 ↗
91. Holoman · J. Neurosci. · 2021 · 41 · 327510.1523/JNEUROSCI.2010-20.2021 ↗
92. You · Sci. Rep. · 2017 · 7 · 743710.1038/s41598-017-07942-x ↗
93. Liu · Int. J. Nanomed. · 2015 · 10 · 2735
94. Singhal · Sci. Transl. Med. · 2021 · 13 · eabe680510.1126/scitranslmed.abe6805 ↗
95. Lio · ACS Sens. · 2018 · 3 · 164710.1021/acssensors.8b00321 ↗
96. Regazzi · Expert Opin. Ther. Targets · 2018 · 22 · 15310.1080/14728222.2018.1420168 ↗
97. Bai · Int. J. Nanomed. · 2020 · 15 · 971710.2147/IJN.S276001 ↗
98. Arantes · Colloids Surf. B Biointerfaces · 2020 · 188 · 11074910.1016/j.colsurfb.2019.110749 ↗
99. He · Clin. Transl. Med. · 2021 · 11 · e46810.1002/ctm2.468 ↗
100. Awasthi · J. Drug Delivery Sci. Technol. · 2022 · 74 · 10353410.1016/j.jddst.2022.103534 ↗